Asenapine Maleate
6 NDCs across 2 manufacturers|3 Generic,3 Brand
Asenapine Maleate is used to treat bipolar disorder and schizophrenia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 13, 2009, and the first generic was approved Dec 10, 2020. FDA's Orange Book lists 11 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $25 million on Asenapine Maleate across 72,000 claims for 11,000 beneficiaries.
Asenapine Maleate is available as 6 NDCs from 2 manufacturers (3 generic, 3 brand), with NADAC prices from $2.15 to $21.18 per EA — the most expensive product costs about 9.9× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
3G / 3B
Manufacturers
2
competing in market
Price Spread
$2.15 – $21.18
per EA
7d Activity
avg -2.1% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing ASENAPINE MALEATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SAPHRIS 5 MG TAB SUBLINGUAL | $21.1808 per EA | -0.17% |
SAPHRIS 10 MG TAB SUBLINGUAL | $21.1603 per EA | +0.04% |
SAPHRIS 2.5 MG TAB SUBLINGUAL | $20.9943 per EA | — |
ASENAPINE 2.5 MG TABLET SL | $3.1169 per EA | +0.40% |
ASENAPINE 10 MG TABLET SL | $2.9254 per EA | -2.37% |
ASENAPINE 5 MG TABLET SL | $2.1475 per EA | -8.53% |
Frequently Asked Questions
What is Asenapine Maleate used to treat?
Asenapine Maleate is used to treat bipolar disorder and schizophrenia, per the National Library of Medicine's MED-RT classification.
When did Asenapine Maleate become available as a generic?
FDA approved the first generic Asenapine Maleate (ANDA) on Dec 10, 2020. The Orange Book currently lists 11 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Asenapine Maleate?
In 2024, Medicare Part D spent $25 million on Asenapine Maleate across 72,000 claims for 11,000 beneficiaries.
How many Asenapine Maleate products are on the market?
The Asenapine Maleate drug market contains 6 NDCs from 2 manufacturers — 3 generic and 3 brand products.
What is the price range for Asenapine Maleate?
NADAC reference prices for Asenapine Maleate range from $2.1475 to $21.1808 per EA — the most expensive product costs about 9.9× the cheapest.
Is generic Asenapine Maleate cheaper than brand?
The average generic NADAC for Asenapine Maleate is $2.7300 per EA, versus $21.1118 for brand-labeled products — brand versions average about 7.7× the generic price.
Which manufacturers make Asenapine Maleate?
2 manufacturers list Asenapine Maleate in NADAC. Ranked by number of NDCs, the largest are Allergan, Inc. (3), Breckenridge Pharmaceutical Inc. (3).
How has the price of Asenapine Maleate changed recently?
Over the past 7 days, 2 Asenapine Maleate NDCs rose and 3 fell, with a market-wide average change of -2.1%.